A detailed history of Accretive Wealth Partners, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Accretive Wealth Partners, LLC holds 11,600 shares of EXEL stock, worth $413,076. This represents 0.13% of its overall portfolio holdings.

Number of Shares
11,600
Previous 11,600 -0.0%
Holding current value
$413,076
Previous $260,000 15.77%
% of portfolio
0.13%
Previous 0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$20.17 - $23.93 $233,972 - $277,588
11,600 New
11,600 $275,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Accretive Wealth Partners, LLC Portfolio

Follow Accretive Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accretive Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accretive Wealth Partners, LLC with notifications on news.